Nobel Prize winner Carol Greider signs strategic cooperation agreement with BLG Group

Enzyme Research and Intelligence Scientists Conference 2024-11-12 296

 

The 2024 Scientists (Global) Conference was successfully held in Suqian. During the conference, at the roundtable forum, Nobel Prize winner in Medicine Carol W. Greider and Dr. Zhou Xunyong, Chairman of the Scientists (Global) Conference, as dialogue guests, had a wonderful in-depth exchange and collision of ideas on the theme of "Enzyme-based Technology and Healthy Future". As leading figures in the field of enzyme technology, the two experts are committed to promoting the development of enzyme-based technology and are highly compatible in their thinking. Through this dialogue, the two sides further strengthened their confidence in cooperation.

After in-depth exchanges and careful planning, the two parties formally signed a cooperation agreement and announced the establishment of the "Nobel Prize Cooperation Laboratory" to jointly carry out research with the Enzyme-based Science and Technology Innovation Research Institute to jointly promote the leapfrog development of China's enzyme technology.

 

1. Carol Greider: Pioneer in Telomere and Telomerase Research Professor Carol Greider's name is closely linked to telomeres and telomerase.

She received a bachelor of science degree in biology from the University of California, Santa Barbara in 1983 and then went on to complete a doctorate from the University of California, Berkeley. During her doctoral studies, she first discovered the existence of telomerase and revealed its important role in maintaining chromosome stability and regulating cell lifespan. This discovery provides a valuable key to solving life science mysteries such as cell aging and cancer. Telomerase in 2009; Professor Carol Greider won the Nobel Prize in Physiology or Medicine for her outstanding contributions to the study of telomeres and telomerase. Her research has not only had a profound impact in academia, but also brought new perspectives and ideas to the fields of medicine and biotechnology. In addition, she has won numerous prestigious awards. Some include, the Lasker Basic Medical Research Award and the Wiley Biomedical Science Award, which further consolidated her lofty status in the scientific community.

 

2. Enzyme-based technology: the future frontier of biotechnology

BLG Group has been committed to the research and development and the application of enzyme-based technology, aiming to solve problems in the fields of industry, medicine, environmental protection, etc., through biocatalytic technology. Enzymes are very important biocatalysts in nature. They are highly efficient, specific and environmentally friendly. They have broad application prospects in the pharmaceutical industry, chemical, food and other industries.

 

The Group's unique innovative core technology, enzyme-based technology (EBT), develops enzyme-based new raw materials and enzyme-based microecology by improving the activity of enzymes and the effectiveness of bioactive substances This complements Professor Carol Greider's research on telomerase activity regulation and cell protection. Cell therapy (ILDT) uses enzyme-based multi-target cell activation stimulators to activate telomerase activity and immune cell function in cells. We believe that by combining ILDT technology with Professor Carol Greider's achievements in anti-aging and anti-tumor research, more effective treatment plans can be developed.

3. Enzyme-based Technology Innovation Research Institute: Global Enzyme-based Technology Innovation Highland

The Enzyme-based Technology Innovation Research Institute (EBTICI) is an unincorporated public welfare scientific research institution jointly established by BLG Group and Tianjin University of Science and Technology. It provides enzyme engineering, fermentation engineering technology and processes based on enzymology, bioenzyme engineering, microbial fermentation engineering and biotechnology product application research and development. The Enzyme-based Technology Innovation Research Institute actively carries out technological innovation, improves the company's technological innovation capabilities and enhances the company's market competitiveness through technical cooperation and technological development. In addition, we will align to the market entity status of enterprises, make full use of the technological advantages of the center, give full play to their own advantages, form an innovation alliance, and play a positive role in the technological innovation of enterprises.

 

After the completion of the Enzyme-Based Science and Technology Innovation Institute in the near future, BLG Group and Professor Carol Greider will solidify their cooperation. Together they will carry out a series of innovative projects around the cutting-edge research of enzyme-based technology. We look forward to working in collaboration with Professor Carol Greider's which will bring world-class scientific research resources and talent support to the institute and enhance the institute's scientific research strength and international influence. At the signing ceremony, Professor Carol Greider said, "I am very honored to be a visiting professor of BLG Group and to conduct research with the Enzyme-Based Science and Technology Innovation Institute. I believe that through our joint efforts, we will be able to achieve more breakthrough results in the field of enzyme-based technology and make greater contributions to human health."

 

4. Nobel Prize winner Carol and BLG Group jointly promote new breakthroughs in enzyme-based technology

This cooperation is not only a strong alliance between BLG Group and Professor Carol Greider, but also a major leap in the field of global enzyme-based technology. Through collaboration with top international scientists, BLG Group will further enhance its scientific research level and innovation capabilities. This will bring about a qualitative breakthrough in the development of enzyme-based technology. The establishment of the Enzyme-Based Science and Technology Innovation Institute will invite scientists who have made important contributions in the field of global enzyme technology to conduct in-depth research on the frontier theories of enzymology and other interdisciplinary subjects, thereby further promoting the high-quality development of the enzyme-based industry. We believe that with the joint efforts of both parties, the Enzyme-Based Science and Technology Innovation Institute will become a global enzyme-based technology research and innovation highland, bringing more hope and possibilities to the cause of human health.